Comparison of Plasma Concentrations of Aerosolized Pentamidine in Nonventilated and Ventilated Patients with Pneumocystosis
- 1 December 1989
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 140 (6) , 1607-1610
- https://doi.org/10.1164/ajrccm/140.6.1607
Abstract
Pentamidine concentrations were determined in plasma after a single aerosolization of 4 mg/kg pentamidine base on 18 patients breathing spontaneously (Group 1) and in eight patients receiving mechanical ventilation (Group II). All the patients had documented pneumocystosis. Large interindividual variations in concentrations appeared, especially in Group I. Low concentrations were observed in Group I: Cmax = 65.6 .+-. 9.4 .mu.g/L (mean .+-. SEM), contrasting with high levels in Group II: Cmax = 215.8 .+-. 49.8 .mu.g/L (mean .+-. SEM). Consequently, the mean area under the curve from zero to 4 h was 2.6-fold higher in Group II than in Group I. These findings underline the risk of dose-related pentamidine toxicity in ventilated patients treated with aerosolized pentamidine and the interest of plasma pentamidine monitoring.This publication has 7 references indexed in Scilit:
- Aerosol PentamidineAnnals of Internal Medicine, 1988
- Distribution of Pentamidine in Patients with AIDSThe Journal of Infectious Diseases, 1988
- Selective Delivery of Pentamidine to the Lung by AerosolAmerican Review of Respiratory Disease, 1988
- Inhaled or Reduced-Dose Intravenous Pentamidine for Pneumocystis carinii PneumoniaAnnals of Internal Medicine, 1987
- Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in ratsAntimicrobial Agents and Chemotherapy, 1987
- Pentamidine for the Treatment of Pneumocystis carinii Pneumonia and Other Protozoal DiseasesAnnals of Internal Medicine, 1985